Amelioration of cognitive and motor deficits associated with alzheimer's
US2018228787A1
Amelioration of certain deficiencies due to stroke
WO2019094032A1
Amelioration of angelman's syndrome deficiencies
WO2018093681A1
Multipotent neural stem cells that express platelet derived growth factor (pdgf) receptor and methods of use thereof
WO2018075667A1
Amelioration of radiation-induced cognitive dysfunction
CN109952291A
The improvement of neurologically handicapped relevant to diabetes
CA2964927A1
Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof
AU2015277406A1
Protocols for treatment of major depressive disorder (MDD)
WO2015006474A1
Methods of treating a subject with a cognitive dysfunction using spinal cord-derived neural stem cells
WO2014138003A1
Compositions comprising an immunosuppressive drug and/or neural stem cells and methods of using same for the treatment of neurodegenerative diseases and/or disorders
US2013045487A1
Method for discovering neurogenic agents
NZ623207A
Methods for treating and/or reversing neurodegenerative diseases and/or disorders
CN105693601A
Synthesis of a neurostimulative piperazine
US7560553B1
Use of fuse nicotinamides to promote neurogenesis
EP1814979A2
Transplantation of human neural cells for treatment of neurodegenerative conditions
